Home » Topics » Regulatory » Patents

Patents
RSS

Prokinetic agents from Nisshin Flour Milling

Sep. 27, 1996

Tanabe reports t-PA-enhancing compounds

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Bayer investigates agents for arteriosclerosis, restenosis

Sep. 27, 1996

Novel free radical scavengers reported by Merrell

Sep. 27, 1996

Dual ACE/NEP inhibitors from ADIR

Sep. 27, 1996

Mitsui's Na+/H+-exchange inhibitors for cardiovascular disorders

Sep. 27, 1996

Bristol-Myers Squibb continues to search for new ET antagonists

Sep. 27, 1996

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...